June 21, 2024
Analyst: Avalanche (AVAX) In ‘Healthy’ Retreat, Potential Rebound Lies Ahead

Analyst: Avalanche (AVAX) In ‘Healthy’ Retreat, Potential Rebound Lies Ahead

AVAX Price Analysis: March Recap AVAX, the native token of the Avalanche protocol, experienced a rollercoaster ride for investors throughout March. Initially surging by over 64% to surpass $65, it later faced an 18.44% decline

Read More